Nobel 2017 season opens with medicine prize

Agencies
October 2, 2017

Stockholm, Oct 2: This year's Nobel season opens Monday with the announcement of the medicine prize, turning the page on Bob Dylan's literature prize stunner that stole the spotlight in last year's award season.

Like every year, speculation is rife about the possible winners, given the number of worthy laureates in the fields of medicine, physics, chemistry, literature, peace and economics.

The Nobel medicine prize committee at the Karolinska Institute is first out to announce its choice of laureates, on Monday at 11:30 am (0930 GMT) at the earliest.

Sweden's newspaper of reference, Dagens Nyheter, suggested American oncologist Dennis Slamon could be honoured for his research on breast cancer and the drug treatment Herceptin.

Or possibly American James Allison, a pioneer in the field of immunotherapy that combats cancer cells and the winner of the 2015 Lasker Prize -- often considered the US equivalent of a Nobel medicine prize. If this method were awarded, Allison could share the prize with Arlene Sharpe and Gordon Freeman.

Meanwhile Swedish public radio SR tipped the prize could go to researchers who worked on a cure for Hepatitis C, Ralf Bartenschlager of Germany and Americans Charles Rice and Michael Sofia -- a trio also awarded the Lasker Prize, in 2016.

Waves, scissors or batteries?

The medicine prize will be followed by the physics prize announcement on Tuesday, with the discovery of gravitational waves regularly mentioned as a possible winner.

Sending ripples through space and time, gravitational waves were first predicted by Albert Einstein a century ago as part of his theory of general relativity, but the first hard evidence of their existence came only in 2015, when two US detectors found the first such signal.

That discovery could however be considered too recent by the Nobel committee.

According to Dagens Nyheter, the jury could instead choose to honour the discovery of exoplanets by Swiss astrophysicians Michel Mayor and Didier Queloz.

On Wednesday, the chemistry prize committee could give the nod to a gene-editing technique known as the CRISPR-Cas9 DNA snipping tool, a type of genetic "scissors" used to cut out a mutated gene in a human embryo and replace it by a corrected version.

But that discovery could also be too early for a Nobel, as a legal dispute rages over who discovered the technique.

It has been claimed on the one hand by the French-American research duo of Emmanuelle Charpentier and Jennifer Doudna, and on the other by Chinese-born American Feng Zhang.

Another recurring favourite for the chemistry prize is John Goodenough, a 95-year old electrochemist whose pioneering work led to the invention of rechargeable lithium ion battery present in cell phones, computers and electric cars.

Anti-nuke buzz for peace prize

Perhaps the most watched Nobel is the peace prize, the only one to be announced in Oslo and due on Friday.

This year, anti-nuclear efforts could win, some have suggested. Tensions have escalated between Washington and Pyongyang after North Korea's sixth nuclear test, and there is growing uncertainty over the Iran deal, which US President Donald Trump has threatened to tear up.

Two key orchestrators of that accord, Iranian Foreign Minister Mohammad Javad Zarif and EU foreign policy chief Federica Mogherini, are seen as strong contenders by the head of the Peace Research Institute of Oslo (Prio), Henrik Urdal.

"With North Korea also at stake, it's very important to support initiatives that guard against the development and proliferation of nuclear weapons," he said.

The names of the candidates are kept secret for at least 50 years, but those eligible to nominate candidates — including former laureates, lawmakers and government ministers around the world, and some university professors — are allowed to disclose their choices.

Those believed to be on the list include Syria's White Helmets rescue service, Congolese doctor Denis Mukwege, jailed Saudi blogger Raif Badawi and Edward Snowden, who revealed the scope of America's NSA electronic surveillance programme.

Meanwhile, the Swedish Academy has yet to set the date for its literature prize announcement, but it traditionally falls on a Thursday so October 5 and 12 are seen as possible dates.

The Academy's choice of US singer songwriter Bob Dylan last year was so divisive that Stockholm's literary circles have predicted the Academy will go for a more conservative name this year, such as Italy's Claudio Magris, Kenya's Ngugi wa Thiong'o, Canadian author Margaret Atwood or Syrian poet Adonis.

The economics prize will be announced on October 9.

This year, each Nobel comes with a nine million kronor ($1.1-million, 940,500-euro) prize sum, to be shared if several laureates are honoured in the same discipline.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
August 6,2020

New Delhi Aug 6: In a new twist in the Vijay Mallya case, a certain document connected with the case in the Supreme Court has gone missing from the apex court files. 

A bench comprising Justices U.U. Lalit and Ashok Bhushan adjourned the hearing to August 20.

It was hearing the review plea filed by Mallya against a July 14, 2017 judgment wherein he was found guilty of contempt for not paying Rs 9,000 crore dues to banks despite repeated directions, although he had transferred $40 million to his children.

The bench was looking for a reply on an intervention application, which it seemed has gone missing from the case papers.Parties involved in the case sought more time to file fresh copies.

On June 19, the Supreme Court sought explanation from its registry regarding Mallya's appeal against the May 2017 conviction in the contempt case for not repaying Rs 9,000 crore dues to banks not listed for the last 3 years.

A bench comprising Justices Lalit and Bhushan had asked the Registry to furnish all the details including names of the officials who had dealt with the file concerning the Review Petition for last three years.

The bench said according to the record, placed before it, the review petition was not listed before the court for last three years. "Before we deal with the submissions raised in the Review Petition, we direct the Registry to explain why the Review Petition was not listed before the concerned Court for last three years," said the bench.In May 2017, the apex court held him guilty of contempt of court for transferring $40 million to his children, and ordered him to appear on July 10 to argue on the quantum of punishment.

The bench said let the explanation be furnished within two weeks. "The Review Petition shall, thereafter, be considered on merits," it added.In 2017, the apex court passed the order on a contempt petition against Mallya by a consortium of banks led by the SBI. 

The banks claimed Mallya transferred $40 million from Daigeo to his children's accounts, and did not use this money to clear his debt. Banks cited this as violation of judicial orders.

stm88 info live rtp slot

slot auto scatter hitam

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 31,2020

Washington, Mar 31: The United States has performed over one million coronavirus tests so far, said President Donald Trump on Monday.

"Today, we reached a historic milestone in our war against coronavirus. Over 1 million Americans have now been tested, more than any other country by far, not even close," Trump said during a press briefing.

US Health Secretary Alex Azar said that approximately 100,000 samples are tested for coronavirus daily.

The number of novel coronavirus (COVID-19) cases within the United States surpassed 150,000 and the death toll has reached 2828, according to Johns Hopkins University. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.